Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Divide your syringe units by 100 to get mL
Normal adjustment, modify your diet
Depending on dose, 64100% of retatrutide-treated individuals achieved at least 5% weight loss (a common benchmark for clinical success) versus 27% on placebo
A 2023 study published in Scientific Reports examined alcohol consumption among people with obesity taking semaglutide or tirzepatide and found that participants reported reduced drinking while on treatment (7)
It is a modified version of insulin-like growth factor-1 engineered to: Resist binding proteins Remain active longer in circulation Increase tissue exposure Once administered, IGF-1 LR3 binds directly to IGF-1 receptors in tissues throughout the body
US$ 24.96
US$ 29.61
US$ 29.12
